This CME/CE course provides healthcare professionals with the latest advancements in diagnosing and treating dementing illnesses, focusing on Alzheimer s. To enhance early and accurate diagnosis, participants will explore cutting-edge diagnostic tools, including biomarkers and imaging technologies. The course also examines amyloid antibody therapies, assessing their risks, benefits, and clinical implications. It also addresses the practical challenges of integrating novel Alzheimer s treatments into clinical practice, equipping providers with strategies for effectively navigating these complexities. By completing this course, participants will gain the knowledge and skills to apply innovative diagnostic and therapeutic approaches, ultimately improving patient care and outcomes in Alzheimer s disease management.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership
| Free CME Activity | Free |
Collected from the provider’s public pages · source
Specialties served/covered
- Clinical Informatics
- Dermatology
- Gastroenterology
- General & Adult Psychiatry
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Gynecologic Oncology
- Health Equity & Inclusion
- Medical Leadership & Administration
- Medical Oncology
- Neonatal-Perinatal Medicine
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Pediatric Neurology
- Sleep Medicine
- Surgical Oncology
- Urological Oncology
- Vascular Neurology
- Cross-Specialty
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Urology
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 1 credit
- $40
-
ReleasedJan 9, 2025
-
Last day to claim creditDec 1, 2026 7 weeks left
-
StitchedHealth, Inc. +1 Advancing Confidence in Safe and Collaborative Implementation of Disease-Modifying Therapy in Early Alzheimer s Disease: An Applied Learning Experience for Specialists
-
Massachusetts Medical Society Alzheimer s Disease and Dementia Care: Diagnosis, Support, and Treatment Strategies
-
touchIME +1 Reimagining Alzheimer s care: Harnessing subcutaneous therapies and early diagnostic innovation to transform patient lives
